CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 74 enrolled
Drug / intervention
Topical Sodermix Dismutase in the form of Sodermix (SOD) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01771991
NCT01771991N/ACompleted
CompareCT.gov

Topical Superoxide Dismutase For the Treatment of Radiation Induced Fibrosis in the Head and Neck Cancer Patient

Sanford Health·interventional·Posted Jan 21, 2013·Updated Apr 5, 2019

In Brief

A clinical study evaluating Topical Sodermix Dismutase in the form of Sodermix (SOD) and Placebo for Radiation Induced Fibrosis to the Head and Neck. Completed, enrolled 74 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if topical superoxide dismutase is an effective treatment of radiation related neck fibrosis, and to determine the quality of life impact from radiation related fibrosis in the head and neck cancer patients at Sanford Health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRadiation Induced Fibrosis to the Head and Neck
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 21, 2013
Enrollment StartAug 1, 2012
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 13.4 years ago

Interventions

Topical Sodermix Dismutase in the form of Sodermix (SOD)drug

Topical Sodermix Dismutase in the form of Sodermix (SOD) will be applied twice daily, of half dollar application for 12 weeks to fibrosed area.

Placebodrug

Placebo or cetaphil cream will be applied twice daily, of half dollar size for 12 weeks to fibrosed area.